Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Telomir Pharmaceuticals, Inc.

NASDAQ: TELO · Life Sciences · 5 alerts · CIK 1971532

Share price
$0.4810Close, Nov 16
Market cap
$35.4M
Shares outstanding
73.68MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Telomir Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:41 PM ET 10-Q
Financial Results

Telomir Pharmaceuticals Q3 2026 Results: Net Loss of $705K, Loss Narrows

Telomir Pharmaceuticals reported a net loss of $3.42 million for the nine months ended September 30, 2026, a significant improvement from the $8.35 million loss in the prior year period. However, the net loss attributable to common stockholders surged to $49.53 million due to a $46.11 million deemed dividend, while cash reserves decreased to $4.52 million from $7.29 million at year-end 2025.

Key figure
Net loss $705K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.